Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The prognostic value and immunological role of CD44 in pan-cancer study
Shaoyong Chen, Siqin Zhang, Shaohua Chen, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 13

Showing 13 citing articles:

An Advanced Multivalent Ligand‐Decorated Microsphere Enrichment System Efficiently Captures Circulating Tumor Cells In Vivo
Xiaojie Wang, Yuan Ji, Jun Luo, et al.
Small (2025)
Open Access | Times Cited: 1
CD44: A New Prognostic Marker in Colorectal Cancer?
Pina Ziranu, Andrea Pretta, Valentina Aimola, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1569-1569
Open Access | Times Cited: 8
Development and Characterization of CD44-Targeted X-Aptamers with Enhanced Binding Affinity for Cancer Therapeutics
Hongyu Wang, Weiguo He, Miguel-Angel Elizondo-Riojas, et al.
Bioengineering (2025) Vol. 12, Iss. 2, pp. 113-113
Open Access
Clinical and Immunohistochemical Effects of OncoTherad (MRB-CFI-1) Nanoimmunotherapy on SERBP1, HABP4, CD44 and Ki-67 in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Maria Izabel de Barros Frazão Salmazo, João Carlos Cardoso Alonso, Gabriela Cardoso de Arruda Camargo, et al.
Tissue and Cell (2025) Vol. 93, pp. 102783-102783
Closed Access
Potentiating anti-tumor immunity by re-engaging immune synapse molecules
Xindi Zhou, Xu Tian, Changhe Li, et al.
Cell Reports Medicine (2025), pp. 101975-101975
Open Access
CD44 and Its Role in Solid Cancers – A Review: From Tumor Progression to Prognosis and Targeted Therapy
João Martins Gama, Rui Caetano Oliveira
Frontiers in Bioscience-Landmark (2025) Vol. 30, Iss. 3
Open Access
Identifying the prognosis implication, immunotherapy response prediction value, and potential targeted compound inhibitors of integrin subunit α3 (ITGA3) in human cancers
Jiawei Gui, Lufei Yang, Junzhe Liu, et al.
Heliyon (2024) Vol. 10, Iss. 2, pp. e24236-e24236
Open Access | Times Cited: 3
Extracellular Matrix as a Target in Melanoma Therapy: From Hypothesis to Clinical Trials
Yuriy P. Mayasin, Maria N. Osinnikova, Chulpan B. Kharisova, et al.
Cells (2024) Vol. 13, Iss. 22, pp. 1917-1917
Open Access | Times Cited: 3
A paclitaxel-hyaluronan conjugate (ONCOFID-P-B™) in patients with BCG-unresponsive carcinoma in situ of the bladder: a dynamic assessment of the tumor microenvironment
Anna Tosi, Beatrice Parisatto, Enrico Gaffo, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 2
CD44 in Bladder Cancer
Jason E. Duex, Dan Theodorescu
Cancers (2024) Vol. 16, Iss. 6, pp. 1195-1195
Open Access | Times Cited: 1
Are androgen receptor agonists a treatment option in bladder cancer?
Michael L. De Ieso, Ahmed Faris Aldoghachi, Wayne D. Tilley, et al.
The Journal of Steroid Biochemistry and Molecular Biology (2024), pp. 106623-106623
Open Access | Times Cited: 1
Biological Characterization of CD44 and Progress in Malignant Tumors
思岳 田
Advances in Clinical Medicine (2024) Vol. 14, Iss. 06, pp. 1490-1494
Closed Access
Identification of molecular and cellular infection response biomarkers associated with anthrax infection through comparative analysis of gene expression data
Swati Rani, Varsha Ramesh, Mehnaj Khatoon, et al.
Computers in Biology and Medicine (2024) Vol. 184, pp. 109431-109431
Closed Access
Page 1

Scroll to top